Embody vs Hers: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Embody and Hers are tied at 7.3/10. Hers is more affordable at $199/mo vs $299/mo. Choose Embody for people who want the oral tirzepatide gum, or who'll pick the. Choose Hers for women who want brand-name wegovy (injection or pill) at $149.
A side-by-side comparison of Embody and Hers covering pricing, scores, medication types, insurance, and more to help you decide.
Embody
#38 of 48Online weight-loss program that ships compounded GLP-1 medication to your door. Run by Modern Metabolic Medicine, Inc. and prescribed through CareGLP Affiliated P.C.s, their network of licensed doctors. Two pricing plans run side by side: a promo plan starting at $99/mo for semaglutide (or $149/mo for tirzepatide) that jumps after month 1, and 'Embody Flat' at $299/mo that doesn't go up. Their standout: oral tirzepatide gum, for people who don't want to inject.
Visit EmbodyHers
#35 of 48The women's health arm of Hims & Hers Health (NYSE: HIMS). In 2026 Hers signed a direct Novo Nordisk partnership adding FDA-approved Wegovy (pen and pill) at $149/mo and Zepbound via the Lilly partnership — alongside their existing compounded semaglutide and new compounded tirzepatide programs.
Visit Hers| Feature | Embody | Hers |
|---|---|---|
| Our Score | 7.3/10 | 7.3/10 |
| Starting Price | $299/mo | $199/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | People who want the oral tirzepatide gum, or who'll pick the $299/mo flat plan with eyes open instead of the teaser plan | Women who want brand-name Wegovy (injection or pill) at $149/mo via the 2026 Novo Nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand |
| Ranking | #38 | #35 |
Pros & Cons Compared
Embody
Pros
- +Cheap first month — $99 for semaglutide or $149 for tirzepatide. Among the lowest entry prices in the category.
- +Oral tirzepatide gum is rare. Real option for needle-phobic users. (How well it absorbs vs the FDA-approved injection isn't published.)
- +'Embody Flat' plan is $299/mo flat with no surprise increases — predictable if you pick it from the start.
- +100% money-back guarantee in writing: if you follow the program and don't see results in 6 months, they say they'll make it right.
- +Replies to every negative Trustpilot review, usually within 24 hours.
Cons
- −Recurring complaint: people sign up at $149 month 1, get billed $299–$399 in month 2. Embody admits in replies that two plans exist (promo + flat) and the switchover isn't always clear at signup.
- −Trustpilot rating is 3.3 / 5 across 46 reviews — heavily split: 41% love it, 24% give 1 star. Price is the top complaint theme.
- −Embody won't tell you which pharmacy makes the medication — just 'multiple USA certified pharmacies.' This is the norm in the category — most major brands (Embody, Henry, Hims, Yucca, Eden) don't publicly name their pharmacy partners.
- −No HIPAA disclosure on their site (HIPAA is the federal law protecting your medical info — most telehealth providers publish a statement confirming they follow it).
- −Compounded medications only — no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic available.
- −If you stop treatment and come back, Embody's doctors will likely restart you at the lowest dose (2.5mg). It's their safety policy — some users find it overly cautious.
Hers
Pros
- +2026 Novo Nordisk partnership — FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Broader women's health platform — integrates weight loss with hormonal, skin, and wellness services
Cons
- −Membership + medication are billed separately ($39 first month / $149 ongoing membership) — watch the all-in math
- −Generic support experience — large patient volume means less personalized attention
- −Compounded pricing starts at $199/mo but stepped pricing applies at higher doses
- −Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership — read as access, not value
Our Verdict
Embody and Hers are closely matched with identical scores of 7.3/10. If budget is your priority, Hers starts at $199/mo compared to Embody's $299/mo. Hers offers both brand-name and compounded medications, giving you more flexibility. Choose Embody if you want: people who want the oral tirzepatide gum, or who'll pick the $299/mo flat plan with eyes open instead of the teaser plan. Choose Hers if you want: women who want brand-name wegovy (injection or pill) at $149/mo via the 2026 novo nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand.
Read Full Reviews
Related comparisons
Other matchups readers comparing Embody or Hers tend to look at next.
- Embody vs MyStart Health$299/mo
- Embody vs Direct Meds GLP-1$297/mo
- Embody vs Maximus$300/mo
- Hers vs TrimRx$199/mo
- Hers vs Enhance MD$212/mo
- Hers vs Sesame Care$99/mo